Get our newsletter delivered directly to your inbox
I have already subscribed | Do not show this message again
Your email has been successfully registered.
The regional organization warns that 87 percent of medicine imports come from outside the region.
Economic Commission for Latin America and the Caribbean (ECLAC) Executive Secretary Alicia Barcena presented a technical report to boost COVID-19 vaccine production capacity in Latin America and the Caribbean region.
The report analyzed the LATAM pharmaceutical industry to propose a roadmap for regulation strengthening and cooperation links.
Barcena presented a Health Self-Sufficiency Plan aimed at offering universal access to vaccines amid the Covid-19 health emergency and future pandemics.
Highlighting that political unity is essential to achieve integration, she informed about regional actors and strategic institutions that could play a role in pharmaceutical industry cooperation.
There are 4 million Mom-and-pop stores in Latin America and the Caribbean, served by more than 10 million people - 60% women. Shopkeepers are leaders in our neighborhoods and we must support them to achieve an economic recovery of the communities in this region. #Tiendasdebarriohttps://t.co/GdFqb3sFOm
"The main motivation for this plan is the unequal access to vaccination..there are countries such as Chile with a high percentage of vaccinated citizens and Haiti, Guatemala, and Nicaragua with low percentages," Barcena warned.
The plan's goals include a virtual clinical data repository with a regional platform for clinical trials, a transparent and regional mechanism for purchasing vaccines and medicines, and a sub-regional purchasing platform.
"Eighty-seven percent of medicine imports come from outside the region," the ECLAC top figure said while adding that Latin America should work on regulatory bodies and the renewal of the Community of Latin America and Caribbean States' mandate to concrete the proposals.
The COVID-19 vaccines created by #Cuba, Soberana 02 and Abdala, are the first two created in Latin America, and have an efficacy of 62% and 92.28%, respectively. pic.twitter.com/j4eFQYtKpP